Adherex Technologies Inc. (FENC) Reports Q4 Loss, Misses Revenue Estimates

Core Viewpoint - Adherex Technologies Inc. reported a quarterly loss of $0.06 per share, significantly missing the Zacks Consensus Estimate of $0.56, marking an earnings surprise of -110.71% [1][2] Financial Performance - The company posted revenues of $7.93 million for the quarter ended December 2024, which was 73.17% below the Zacks Consensus Estimate and down from $9.74 million year-over-year [2] - Over the last four quarters, Adherex Technologies has not surpassed consensus EPS estimates and has only topped revenue estimates once [2] Stock Performance - Adherex Technologies shares have increased by approximately 8.9% since the beginning of the year, contrasting with a -1.9% decline in the S&P 500 [3] - The current consensus EPS estimate for the upcoming quarter is -$0.17 on revenues of $8.7 million, and for the current fiscal year, it is -$0.15 on revenues of $57.11 million [7] Industry Outlook - The Medical - Biomedical and Genetics industry, to which Adherex Technologies belongs, is currently ranked in the top 26% of over 250 Zacks industries, indicating a favorable outlook compared to the bottom 50% [8]